Formulation and evaluation of ethylene-vinyl acetate copolymer matrix patches containing formoterol fumarate

Biological and Pharmaceutical Bulletin

Volumn 29, Issue 3, 2006, Pages 513-516

  Kakubari, Ikuhiro ^a   Shinkai, Norihiro ^a   Kawakami, Junji ^a   Uruno, Akemi ^a   Takayasu, Toshiyuki ^a   Yamauchi, Hitoshi ^a   Takayama, Satoshi ^a   Takayama, Kozo ^b  

^a DAIICHI SANKYO CO   (Japan)

^b HOSHI UNIVERSITY   (Japan)

Author keywords

Efficacy; Formoterol; L menthol; N methyl 2 pyrrolidone; Skin permeation; Stability

Indexed keywords

1 METHYL 2 PYRROLIDINONE; ETHYLENE VINYL ACETATE COPOLYMER; FORMOTEROL FUMARATE; MENTHOL; ROSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; ASTHMA; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG FORMULATION; DRUG MECHANISM; DRUG PENETRATION; DRUG SAFETY; DRUG SCREENING; DRUG STABILITY; HYDROGENATION; MALE; NONHUMAN; RAT;

ADMINISTRATION, CUTANEOUS; ANIMALS; ANTI-ASTHMATIC AGENTS; BRONCHOCONSTRICTION; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ELECTROCHEMISTRY; ETHANOLAMINES; EXCIPIENTS; HEMODYNAMIC PROCESSES; HISTAMINE; MALE; MASS SPECTROMETRY; MENTHOL; POLYVINYLS; PYRROLIDINONES; RATS; RATS, WISTAR; SKIN ABSORPTION;

EID: 33645214394     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.29.513     Document Type: Article

References (18)

1. Shin S. C., Byun S. Y., Int. J. Pharm., 137, 95-102 (1996).
2. Miyazaki S., Ishii K., Takada M., Yakuzaigaku, 42, 259-263 (1982).
3. Shin S. C., Cho S. J., Drug Dev. Ind. Pharm., 22, 299-305 (1996).
4. Roy S. D., Gutierrez M., Flynn G. L., Cleary G. W., J. Pharm. Sci., 85, 491-495 (1996).
5. Hatanaka T., Oguchi M., Sugibayashi K., Morimoto Y., Chem. Pharm. Bull., 39, 1802-1805 (1991).
6. Miyazaki S., Ishii K., Sugibayashi K., Morimoto Y., Takada M., Chem. Pharm. Bull., 30, 3770-3775 (1982).
7. Miyazaki S., Takeuchi S., Takada M., Ishii K., Chem. Pharm. Bull., 32, 1633-1636 (1984).
8. Ida H., Arzneim.-Forsch., 26, 839-842 (1976).
9. Ida H., Arzneim.-Forsch., 26, 1337-1340 (1976).
10. Kono O., Morita M., Yakuri to Chiryo, 11, 4405-4416 (1983).
11. Nakajima S., Oishi M., Suetsugu S., Kono O., Mitsui K., Iwakura M., Kiso to Rinsho, 17, 3629-3637 (1983).
12. Borodkin S., Tucker F. E., J. Pharm. Sci., 63, 1359-1364 (1974).
13. Musolf M. C., "Transdermal Controlled Systemic Medications," ed. by Chien Y. W., Marcel Dekker Inc., New York, 1987, pp. 93-112.
14. Konzett H., Rössler R., Arch. Exp. Pathol. Pharmakol., 195, 71-74 (1940).
15. Ogiso T., Iwaki M., Paku T., J. Pharm. Sci., 84, 482-488 (1995).
16. Karino A., Hayashi M., Horie T., Awazu S., Minami H., Hanano M., J. Pharmacobio-Dyn., 5, 410-417 (1982).
17. Sokoloski T. D., Higuchi T., J. Pharm. Sci., 51, 172-177 (1962).
18. Sassetti R. J., Fudenberg H. H., Biochem. Pharmacol., 20, 57-66 (1971).